Gencurix

229000-KR:KON

Medical Specialties

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2021

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Medical Specialties Founded 2011

Gencurix, Inc. is engaged in developing and manufacturing cancer diagnostic test kits. Its products include GenesWell BCT, GenesWell ddEGFR Mutation Test, GenesWell CDx EGFR Mutation Test, and GenesWell ddEGFR Mutation Test. The company was founded on September 21, 2011 and is headquartered at Seoul, South Korea.

website

Headquarters

Guro-gu

242 Digital-ro

9th Floor , Hanhwa Bizmetro I

Seoul 08394

82.70.7508.2340

Executives

Name	Title	Gender
Sang-Rae Cho	Chief Executive Officer & Director	Male
Young-Ho Moon, PhD	Chief Technology Officer, Director & VP	Male

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Gencurix - Competitors and Related Companies

How Gencurix stacks up to its peers in the Medical Specialties industry or with competing business segments.